Literature DB >> 171299

Aplastic anemia secondary to methimazole-case report and review of hematologic side effects.

S L Edell, D G Bartuska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 171299

Source DB:  PubMed          Journal:  J Am Med Womens Assoc (1972)        ISSN： 0098-8421


× No keyword cloud information.
  6 in total

1.  Successful treatment of methimazole-induced severe aplastic anaemia in a diabetic patient with other co-morbidities.

Authors:  Cindy V Josol; Myrna Buenaluz-Sedurante; Mark Anthony Sandoval; Gerry Castillo
Journal:  BMJ Case Rep       Date:  2010-12-20

Review 2.  Adverse effects of thyroid hormone preparations and antithyroid drugs.

Authors:  L Bartalena; F Bogazzi; E Martino
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 3.  Adverse immunologic effects of antithyroid drugs.

Authors:  S S Wing; I G Fantus
Journal:  CMAJ       Date:  1987-01-15       Impact factor: 8.262

4.  Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids.

Authors:  J Jakucs; G Pocsay
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

5.  Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study.

Authors: 
Journal:  BMJ       Date:  1988-07-23

Review 6.  Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.

Authors:  M Meyer-Gessner; G Benker; S Lederbogen; T Olbricht; D Reinwein
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.